Item 5.02 (d) Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
JPMorgan Chase & Co. (the "Firm") electedAlicia Boler Davis as a director, effectiveMarch 20, 2023 .Ms. Davis is the Chief Executive Officer ofAlto Pharmacy .Ms. Davis' appointment to a board committee will be disclosed when determined. She was also elected a director ofJPMorgan Chase Bank, N.A . and a manager ofJPMorgan Chase Holdings LLC , and may be elected a director of such other subsidiary or subsidiaries as may be determined from time to time.
A copy of the press release announcing this election is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
(d) Exhibit Exhibit No. Description of Exhibit 99.1JPMorgan Chase & Co Press Release datedJanuary 17, 2023 101 Pursuant to Rule 406 of Regulation S-T, the
cover page is formatted in
Inline XBRL (Inline eXtensible Business Reporting Language). 104 Cover Page Interactive Data File (embedded
within the Inline XBRL document
and included in Exhibit 101). 2
--------------------------------------------------------------------------------
© Edgar Online, source